BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced a conference call and webcast to discuss regulatory updates for the nomlabofusp clinical development program for Friedreich’s Ataxia on Monday, June 23, 2025, at 8:00 am EDT.
To join the webcast, visit this link.
To join by phone, dial 1-877-407-9716 (US) or 1-201-493-6779 (International) and provide conference ID 13754491, or click this link for a return call.
After the event, a replay will be available on the “Events & Presentations” page of Larimar’s website.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.